| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Eiger BioPharmaceuticals, Inc. | GC & Chief Compliance Officer | Stock Option (Right to Buy) | 26.8K | Jan 26, 2023 | Direct | ||
| Rain Oncology Inc. | General Counsel and CCO | Stock Option (Right to Buy) | 0 | Jan 26, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| RAIN | Rain Oncology Inc. | Jan 26, 2024 | 3 | $0 | 4 | Jan 26, 2024 | General Counsel and CCO |
| RAIN | Rain Oncology Inc. | Aug 9, 2023 | 1 | $0 | 4 | Aug 11, 2023 | General Counsel and CCO |
| RAIN | Rain Oncology Inc. | Mar 2, 2023 | 1 | $0 | 4 | Mar 3, 2023 | General Counsel and CCO |
| RAIN | Rain Oncology Inc. | Mar 2, 2023 | 0 | $0 | 3 | Mar 3, 2023 | General Counsel and CCO |
| EIGR | Eiger BioPharmaceuticals, Inc. | Jan 26, 2023 | 1 | $0 | 4 | Jan 30, 2023 | GC & Chief Compliance Officer |
| EIGR | Eiger BioPharmaceuticals, Inc. | Mar 11, 2022 | 2 | $0 | 4 | Mar 11, 2022 | GC & Chief Compliance Officer |
| EIGR | Eiger BioPharmaceuticals, Inc. | Sep 30, 2021 | 1 | $0 | 4 | Oct 1, 2021 | GC & Chief Compliance Officer |
| EIGR | Eiger BioPharmaceuticals, Inc. | Sep 22, 2021 | 0 | $0 | 3 | Oct 1, 2021 | GC & Chief Compliance Officer |